Bison Wealth, LLC Amgen Inc Transaction History

Bison Wealth, LLC

$561 Million
Q3 2024

A detailed history of Bison Wealth, LLC transactions in Amgen Inc stock. As of the latest transaction made, Bison Wealth, LLC holds 6,835 shares of AMGN stock, worth $2.01 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares

6,835

Previous 6,484 5.41%

Holding current value

$2.01 Million

Previous $2.03 Million 8.74%

% of portfolio

0.39%

Previous 0.35%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$309.38 - $337.38 $108,592 - $118,420	351 Added 5.41%	6,835 $2.2 Million
Q1 2024 May 10, 2024	SELL	$268.87 - $324.56 $8,603 - $10,385	-32 Reduced 0.49%	6,484 $1.84 Million
Q4 2023 Jan 30, 2024	SELL	$255.7 - $288.46 $65,459 - $73,845	-256 Reduced 3.78%	6,516 $1.88 Million
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $195,910 - $243,228	896 Added 15.25%	6,772 $1.82 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $199,485 - $235,887	931 Added 18.83%	5,876 $1.3 Million
Q1 2023 May 15, 2023	BUY	$225.79 - $275.2 $639,663 - $779,641	2,833 Added 134.14%	4,945 $1.2 Million
Q4 2022 Feb 10, 2023	SELL	$229.03 - $291.01 $39,622 - $50,344	-173 Reduced 7.57%	2,112 $554,000
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $17,283 - $19,492	77 Added 3.49%	2,285 $515,000
Q2 2022 Jul 22, 2022	SELL	$230.71 - $256.74 $4,844 - $5,391	-21 Reduced 0.94%	2,208 $537,000
Q1 2022 May 12, 2022	BUY	$219.27 - $242.57 $5,043 - $5,579	23 Added 1.04%	2,229 $539,000
Q4 2021 Feb 02, 2022	SELL	$198.88 - $227.6 $41,963 - $48,023	-211 Reduced 8.73%	2,206 $496,000
Q3 2021 Nov 03, 2021	SELL	$212.27 - $248.7 $22,925 - $26,859	-108 Reduced 4.28%	2,417 $514,000
Q2 2021 Aug 02, 2021	BUY	$233.58 - $259.14 $65,635 - $72,818	281 Added 12.52%	2,525 $615,000
Q1 2021 May 05, 2021	SELL	$221.91 - $258.6 $99,415 - $115,852	-448 Reduced 16.64%	2,244 $558,000
Q4 2020 Feb 11, 2021	BUY	$216.38 - $257.67 $88,499 - $105,387	409 Added 17.92%	2,692 $619,000
Q2 2020 Aug 03, 2020	SELL	$197.81 - $242.74 $17,011 - $20,875	-86 Reduced 3.63%	2,283 $538,000
Q1 2020 May 04, 2020	SELL	$182.24 - $241.7 $44,466 - $58,974	-244 Reduced 9.34%	2,369 $480,000
Q4 2019 Feb 05, 2020	SELL	$189.21 - $243.2 $35,382 - $45,478	-187 Reduced 6.68%	2,613 $630,000
Q3 2019 Nov 04, 2019	SELL	$174.11 - $208.62 $35,170 - $42,141	-202 Reduced 6.73%	2,800 $542,000
Q2 2019 Aug 05, 2019	SELL	$166.7 - $195.41 $67,513 - $79,141	-405 Reduced 11.89%	3,002 $553,000
Q1 2019 May 09, 2019	SELL	$180.87 - $203.88 $212,703 - $239,762	-1,176 Reduced 25.66%	3,407 $647,000
Q4 2018 Feb 08, 2019	SELL	$178.4 - $208.25 $17,483 - $20,408	-98 Reduced 2.09%	4,583 $892,000
Q3 2018 Nov 09, 2018	BUY	$185.29 - $208.89 $16,490 - $18,591	89 Added 1.94%	4,681 $970,000
Q2 2018 Aug 09, 2018	SELL	$166.05 - $186.51 $6,974 - $7,833	-42 Reduced 0.91%	4,592 $848,000
Q1 2018 May 08, 2018	SELL	$169.43 - $198.0 $14,740 - $17,226	-87 Reduced 1.84%	4,634 $790,000
Q4 2017 Jan 29, 2018	BUY	$168.79 - $188.59 $337 - $377	2 Added 0.04%	4,721 $821,000
Q3 2017 Oct 27, 2017	BUY	$167.29 - $191.0 $789,441 - $901,329	4,719	4,719 $880,000

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bison Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bison Wealth, LLC with notifications on news.

Account